 | Up a level |
Wollenberg, A; Kinberger, M; Arents, B; Aszodi, N; Barbarot, S; Bieber, T; Brough, H A; Pinton, P Calzavara; Christen-Zaech, S; Deleuran, M; Dittmann, M; Fosse, N; Gáspár, K; Gerbens, L A A; Gieler, U; Girolomoni, G; Gregoriou, S; Mortz, C G; Nast, A; Nygaard, U; ... (2023). First Update of the Living European Guideline (EuroGuiDerm) on Atopic Eczema. Journal of the European Academy of Dermatology and Venereology : JEADV, 37(11), e1283-e1287. Wiley 10.1111/jdv.19269
Kwatra, Shawn G; Yosipovitch, Gil; Legat, Franz J; Reich, Adam; Paul, Carle; Simon, Dagmar; Naldi, Luigi; Lynde, Charles; De Bruin-Weller, Marjolein S; Nahm, Walter K; Sauder, Maxwell; Gharib, Rola; Barbarot, Sebastien; Szepietowski, Jacek C; Conrad, Curdin; Fleischer, Alan; Laquer, Vivian T; Misery, Laurent; Serra-Baldrich, Esther; Lapeere, Hilde; ... (2023). Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis. The New England journal of medicine, 389(17), pp. 1579-1589. Massachusetts Medical Society 10.1056/NEJMoa2301333
